Flying under the radar: the new wave of BCR–ABL inhibitors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.nature.com/articles/nrd2324.pdf
Reference130 articles.
1. Shtivelman, E., Lifshitz, B., Gale, R. P. & Canaani, E. Fused transcript of ABL and BCR genes in chronic myelogenous leukaemia. Nature 315, 550–554 (1985).
2. Ben-Neriah, Y., Daley, G. Q., Mes-Masson, A. M., Witte, O. N. & Baltimore, D. The chronic myelogenous leukemia-specific p210 protein is the product of the BCR/ABL hybrid gene. Science 233, 212–214 (1986).
3. Ravandi, F. et al. Chronic myelogenous leukaemia with p185(BCR/ABL) expression: characteristics and clinical significance. Br. J. Haematol. 107, 581–586 (1999).
4. Daley, G. Q., Van Etten, R. A. & Baltimore, D. Induction of chronic myelogenous leukemia in mice by the p210 Bcr/Abl gene of the Philadelphia chromosome. Science 247, 824–830 (1990).
5. Lugo, T. G., Pendergast, A. M., Muller, A. J. & Witte, O. N. Tyrosine kinase activity and transformation potency of BCR–ABL oncogene products. Science 247, 1079–1082 (1990).
Cited by 274 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Engineered poly(A)-surrogates for translational regulation and therapeutic biocomputation in mammalian cells;Cell Research;2024-01-04
2. Single amino acid–based PROTACs trigger degradation of the oncogenic kinase BCR–ABL in chronic myeloid leukemia (CML);Journal of Biological Chemistry;2023-08
3. Visible-light-mediated photocatalytic sequential N-arylation: an eco-friendly synthetic route to unsymmetrical diarylamines and the imatinib drug;Organic Chemistry Frontiers;2023
4. Rational combinations of targeted cancer therapies: background, advances and challenges;Nature Reviews Drug Discovery;2022-12-12
5. Cobalt‐Catalyzed Deaminative Amino‐ and Alkoxycarbonylation of Aryl Trialkylammonium Salts Promoted by Visible Light;Angewandte Chemie International Edition;2022-11-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3